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Objective: The objective of the current study is to deﬁne whether intra-articular nerve growth factor
(NGF), an inﬂammatory mediator that contributes to osteoarthritic pain, is necessary and sufﬁcient for
the development or maintenance of injury-induced facet joint pain and its concomitant spinal neuronal
hyperexcitability.
Method: Male Holtzman rats underwent painful cervical facet joint distraction (FJD) or sham procedures.
Mechanical hyperalgesia was assessed in the forepaws, and NGF expression was quantiﬁed in the C6/C7
facet joint. An anti-NGF antibody was administered intra-articularly in additional rats immediately or 1
day following facet distraction or sham procedures to block intra-articular NGF and test its contribution
to initiation and/or maintenance of facet joint pain and spinal neuronal hyperexcitability. NGF was
injected into the bilateral C6/C7 facet joints in separate rats to determine if NGF alone is sufﬁcient to
induce these behavioral and neuronal responses.
Results: NGF expression increases in the cervical facet joint in association with behavioral sensitivity
after that joint's mechanical injury. Intra-articular application of anti-NGF immediately after a joint
distraction prevents the development of both injury-induced pain and hyperexcitability of spinal neu-
rons. Yet, intra-articular anti-NGF applied after pain has developed does not attenuate either behavioral
or neuronal hyperexcitability. Intra-articular NGF administered to the facet in naïve rats also induces
behavioral hypersensitivity and spinal neuronal hyperexcitability.
Conclusion: Findings demonstrate that NGF in the facet joint contributes to the development of injury-
induced joint pain. Localized blocking of NGF signaling in the joint may provide potential treatment for
joint pain.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Joint and neck/back pain are the most common types of chronic
pain1. The ﬁbers that innervate articular joints exhibit increased
mechanosensitivity during joint inﬂammation and can be activated
by joint loading2e4. Joint inﬂammation also sensitizes neurons in
the spinal cord and expands receptive ﬁelds to include adjacent
non-inﬂamed tissues4,5, supporting spinal neuronal sensitization in. A. Winkelstein, Department
. 33rd Street, 240 Skirkanich
3-4589; Fax: 1-215-573-2071.
as), skartha@seas.upenn.edu
in).
ternational. Published by Elsevier Ljoint pain. However, the local joint mechanism(s) through which
spinal neurons are sensitized and induce joint-mediated pain are
not deﬁned.
The spinal facet joint is the most common source of pain from
neck injury6. Non-physiological loading of the facet activates
nociceptors in its capsule, induces hyperexcitability of spinal neu-
rons, and produces pain3,7e9. Intra-articular treatment with an
NSAID alleviates pain after experimental facet trauma and reduces
spinal astrocytic activation10, suggesting inﬂammation is involved
in loading-induced facet pain. Neuro-inﬂammatory responses also
contribute to osteoarthritis-induced joint pain; inﬂammatory cy-
tokines and spinal neuronal hyperexcitability increase in arthritis
models11,12. Because similar inﬂammatory and neuronal responses
are associated with both arthritis-induced and injury-induced jointtd. All rights reserved.
J.V. Kras et al. / Osteoarthritis and Cartilage 23 (2015) 1999e20082000pain5,8e10,12,13, common mechanisms may contribute to both syn-
dromes. Despite evidence suggesting that notion, the local molec-
ular mechanisms that lead to facet pain are unclear.
Nerve growth factor (NGF) sensitizes adult sensory neurons and
increases in inﬂamed tissues14. NGF injection into peripheral tis-
sues induces sensitivity tomechanical stimuli in animalmodels and
humans15,16. Anti-NGF antibody treatment alleviates pain from
inﬂammation and nerve injury in rat models17,18, and systemic anti-
NGF reduces osteoarthritic joint pain19, supporting NGF's role in
joint pain. NGF and its high-afﬁnity receptor, trkA, have been
identiﬁed in osteoarthritic joints and degenerative facets11,20e22.
Although studies collectively suggest intra-articular NGF contrib-
utes to degenerative joint pain, its contribution to injury-induced
facet pain is unknown.
We have developed a rat model of painful facet joint injury, in
which inﬂammatory cytokines and prostaglandin E2 (PGE2) in-
crease in association with pain, and in which intra-articular NSAID
administration alleviates pain8,10,23,24. Since those ﬁndings suggest
either local or widespread inﬂammation to be involved in injury-
induced joint pain, and because NGF is upregulated in painful
inﬂamed and arthritic joints clinically and experimentally11,20,25e27,
intra-articular NGF is hypothesized to contribute to the develop-
ment and/or maintenance of injury-induced facet joint pain. This
study quantiﬁes expression of NGF in the facet joint in order to
determine whether NGF is a local mediator leading to joint pain.
Based on those ﬁndings, complementary studies blocking intra-
articular NGF signaling after facet injury and applying exogenous
NGF intra-articularly to the facet joints of naïve rats were per-
formed to determine if NGF is necessary and sufﬁcient for the
development and maintenance of facet-mediated pain and asso-
ciated spinal neuronal hyperexcitability.
Methods
All procedures were approved by the University of Pennsylvania
IACUC and performed under the guidelines of the Committee for
Research and Ethical Issues of the IASP28. Complementary studies
were performed to: (1) characterize NGF expression in the facet
joint after its painful injury, (2) deﬁne the contribution of intra-
articular NGF to injury-induced facet pain and spinal neuronal
hyperexcitability, and (3) identify whether intra-articular NGF
alone is sufﬁcient to induce pain and spinal neuronal hyperexcit-
ability. Rats were doubly-housed with 12-h light/dark cycles. For all
studies, rats were randomly assigned to groups before any surgical
procedure or behavioral assessment. Multiple groups were evalu-
ated simultaneously, and all quantitative analyses performed
without group identiﬁcation, to eliminate bias.
Facet joint distraction (FJD) & pain assessment
Surgical procedures were performed using male Holtzman rats
(weight 398 ± 31 g) under inhalation isoﬂurane anesthesia (4%
induction; 2.5% maintenance). The painful FJD has been described
previously23,24. The C5-T1 laminae and facet joints were exposed
and cleared of paraspinal musculature. The interspinous ligaments
from C5-T1 were resected, and a customized loading device applied
a symmetric distraction across the bilateral C6/C7 facet joints by
displacing the C6 vertebra rostrally and holding C7 ﬁxed. In sepa-
rate control rats, sham procedures included device attachment
with no joint distraction. Wounds were closed with polyester su-
ture and surgical staples, and rats were recovered in room air with
weight gain monitored regularly until each rat's study endpoint.
Forepaw mechanical withdrawal thresholds were quantiﬁed
using customary methods29,30 and performed between 8am and
noon. An ascending series of von Frey ﬁlaments (Stoelting; WoodDale, IL) was applied to the forepaw of each rat; the lower of two
consecutive ﬁlaments eliciting an emphatic lifting was taken as the
threshold for that paw. The bilateral responses were averaged to
obtain the withdrawal threshold for each rat on each day. Thresh-
olds were quantiﬁed prior to any surgical procedure to establish
baseline responses, as well as until the time of tissue harvest or
electrophysiological experiments.
Intra-articular NGF characterization after painful FJD
NGF expression was quantiﬁed in the facet joint soft tissues,
including the capsular ligament and synovium, from a group of rats
at 1 day after injury (FJD n ¼ 5; sham n ¼ 5) using Western blot
(Table I). Following behavioral assessment, rats were given an
overdose of sodium pentobarbital (65 mg/kg) and transcardially
perfused with phosphate buffered saline (PBS). Tissue was har-
vested from the bilateral C6/C7 facet joints and protein extracted
using the RIPA Lysis Buffer System (Santa Cruz Biotechnology;
Santa Cruz, CA). Proteins were prepared, separated, and transferred
to an Immobilon-FL transfer membrane (Millipore; Billerica, MA),
as described previously31. Membranes were blocked for 1 h with 5%
nonfat dry milk in 0.1% Tween-20 Tris-buffered saline (TBS) and
incubated overnight at 4C with a rabbit anti-NGF antibody (1:200;
Santa Cruz Biotechnology). Membranes were then washed three
times with 0.1% Tween-20 TBS and incubated for 2 h at room
temperature with a goat anti-rabbit IRDye 800CW secondary
antibody (1:15,000; LI-COR; Lincoln, NE). Membranes were imaged
using the Odyssey Infrared Imaging System (LI-COR), then stripped
and re-probed for b-tubulin using mouse anti-b-tubulin primary
(1:2000; Covance; Princeton, NJ) and goat anti-mouse IRDye 680LT
secondary (1:15,000 with 0.02% SDS; LI-COR) antibodies. Quanti-
tative analysis of NGF (27 kDa) and b-tubulin (50 kDa) was per-
formed using Image Studio Lite software (version 3.1; LI-COR). NGF
expression was normalized to b-tubulin for each sample.
NGF expression was also assessed in the facet joints of addi-
tional rats at day 1 (FJD n ¼ 3; sham n ¼ 3) using immunohisto-
chemistry (Table I). The C4-T2 spines were harvested and post-ﬁxed
in 4% paraformaldehyde in PBS, transferred to 30% sucrose in PBS
for 7 days, and decalciﬁed in 10% Ethylenediaminetetraacetic Acid
in PBS for 3 weeks. The C6/C7 spinal levels were embedded in
Tissue-Tek OCT Compound (Sakura Finetek; Torrance, CA). The
bilateral facet joints were sectioned (16 mm) in the frontal plane,
thaw-mounted onto slides, and labeled for NGF as previously
described32. Endogenous peroxidase activity was quenched, and
sections were incubated in DeCal Antigen Retrieval (BioGenex;
Fremont, CA) solution for 30min. Slides werewashed, blocked with
normal horse serum (Vector; Burlingame, CA), and incubated in
rabbit anti-NGF (1:250; Santa Cruz Biotechnology) antibody over-
night at 4C. Sections were then incubated with a biotinylated
horse anti-rabbit secondary antibody (1:1000; Vector) for 30 min
and developed with 3,3-diaminobenzidine (Vector). Additional
tissue sections that were not incubated with the primary antibody
were included as negative controls.
Contribution of intra-articular NGF to injury-induced pain &
neuronal hyperexcitability
In order to determine if intra-articular NGF contributes to the
development and/or maintenance of injury-induced joint pain, NGF
signaling was blocked in the joint using an anti-NGF antibody
either at the time of injury or 1 day after injury. Separate groups of
rats underwent FJD or sham procedures as described above and
received bilateral intra-articular injections of either a commercially
available rabbit polyclonal anti-NGF antibody (IgG fraction) (Milli-
pore #AB1526SP; Billerica, MA) or a control rabbit IgG (Millipore;
Table I
Number of rats for each experimental group and experimental outcomes
Study Group Study endpoint (day) Rats/Group Experimental outcomes
NGF
Characterization
FJD 1 8 Forepaw withdrawal threshold
NGF level (western blot; IHC)sham 8
Intra-articular
Anti-NGF
Injection
sham þ veh 7 5 Forepaw withdrawal threshold
Evoked spinal neuronal ﬁringsham þ anti-NGF 5
FJD þ anti-NGF 6
FJD þ veh 5
FJD þ anti-NGFD1 8
sham þ veh 1 5 Forepaw withdrawal threshold
Evoked spinal neuronal ﬁringFJD þ anti-NGF 5
FJD þ veh 5
Intra-articular
NGF Injection
NGF 7 6 Forepaw withdrawal threshold
Vehicle 3
NGF 1 7 Forepaw withdrawal threshold
Evoked spinal neuronal ﬁringVehicle 6
IHC: immunohistochemistry; veh: vehicle control rabbit IgG; anti-NGFD1: anti-NGF applied at day 1 after injury; Vehicle: vehicle of sterile phosphate buffered saline.
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Immediately following FJD, groups of rats received a bilateral 10 mg
intra-articular injection of either the anti-NGF antibody (FJDþ anti-
NGF) or control IgG (FJD þ veh) in 5 mL of PBS, a dose previously
used in a rat model of inﬂammatory pain33. In a separate group of
rats, anti-NGF was injected into the bilateral facet joints on day 1
after FJD (FJDþ anti-NGFD1). Following behavioral testing on day 1,
those rats were re-anesthetized, the bilateral C6/C7 facet joints
were re-exposed, and 10 mg of anti-NGF in 5 mL of PBS was injected
intra-articularly. Separate rats received bilateral intra-articular in-
jections of the anti-NGF antibody (sham þ anti-NGF) or control IgG
(sham þ veh) immediately following sham procedures. Previous
work with this model demonstrates group sizes of 4e6 rats as
sufﬁcient to detect injury-induced behavioral hypersensitivity and
increased evoked ﬁring from spinal neurons7,10. As such, group
sizes of ﬁve or six rats were utilized, with eight rats used in the
FJD þ anti-NGFD1 group (Table I).
Forepaw mechanical withdrawal thresholds were measured in
all rats as described above in order to assess baseline and post-
surgical responses on days 1, 3, 5, and 7, according to each
group's designated endpoint in the study. Rats were prepared for
spinal electrophysiological recordings on day 1 (FJD þ veh n ¼ 5;
FJD þ anti-NGF n ¼ 5; sham þ veh n ¼ 5) or day 7 (FJD þ veh n ¼ 5;
FJD þ anti-NGF n ¼ 6; sham þ veh n ¼ 5; sham þ anti-NGF n ¼ 5;
FJD þ anti-NGFD1 n ¼ 8) after behavioral testing (Table I)7. Rats
were anesthetized with sodium pentobarbital (45 mg/kg, i.p.), and
anesthesia was maintained with supplementary doses (5e10 mg/
kg, i.p.). The mid-cervical trachea was exposed, cannulated, and
ventilated (CWE Inc.; Ardmore, PA); the rat was mounted onto a
stereotaxic frame. The C6eC8 spinal cord was exposed and bathed
in 37C mineral oil. Core temperature was maintained at 35e37C.
Extracellular potentials were recorded in the C6eC7 spinal cord
using tungsten electrodes lowered into the deep laminae (IIIeVI) of
the dorsal horn, where mostly wide dynamic range (WDR) neurons
are7,9,34, using a micropositioner. The signal was ampliﬁed, ﬁltered,
and sampled at 25 kHz29. Sensory neurons with input from the
forepaw were identiﬁed by brushing the plantar surface of the
forepaw. A stimulus train, consisting of light brush (applied for
10 s), a series of non-noxious and noxious von Frey ﬁlaments (1.4 g,
4 g, 10 g, 26 g) each applied for ﬁve stimulations of 1-s followed by
1-s of recovery, and a noxious pinch (applied for 10 s), was applied
to the paw. Stimulus trains were applied at 30 s intervals.
Recordings were spike-sorted using Spike2 (CED; Cambridge,
UK). Evoked spikes were summed over the continuous 10-s stim-
ulus period for both the brush and pinch stimuli. Evoked spikes
during the pinch stimulus were used to classify neurons as either
low threshold mechanoreceptive (LTM) or WDR9. The number ofspikes evoked from the initial application of a von Frey ﬁlament
until 1-s after its ﬁfth application were summed. For each ﬁlament,
baseline ﬁring was quantiﬁed by counting the number of spikes 1-s
prior to its initial application and was subtracted from the total
spike count.
Behavioral & neuronal response assessments after intra-articular
NGF
In order to determine if intra-articular NGF alone is sufﬁcient to
induce behavioral sensitivity and spinal neuronal hyperexcitability,
rats received either 3 mg of rat b-NGF (R&D Systems; Minneapolis,
MN) in 5 mL of sterile PBS (NGF) or the delivery vehicle alone
(vehicle) injected intra-articularly into the bilateral C6/C7 facet
joints. This dose was selected from an initial doseeresponse study
administering intra-articular NGF at 1 mg, 3 mg, 6 mg, or 10 mg in
separate groups. The 3 mg dose was the lowest to elicit a behavioral
response after injection and so was applied in the current study.
Forepaw withdrawal thresholds to mechanical stimuli were
measured to establish baseline responses, as well as at days 1, 3, 5,
and 7 after injection (Table I). Based on those behavioral studies,
additional separate groups were followed for 1 day (NGF n ¼ 7;
vehicle n ¼ 6) and prepared for spinal electrophysiological re-
cordings after behavior testing on day 1 (Table I). Evoked spikes
from spinal neurons were quantiﬁed as described above.
Statistical analyses
Statistical analyses were performed using JMP Pro v10.0.2 (SAS
Institute Inc.; Cary, NC). A t-test compared NGF levels quantiﬁed via
Western blot between the FJD and sham groups. Forepaw with-
drawal thresholds were compared between groups using a two-
way repeated measures ANOVA with group and time as factors
and a post hoc Tukey's HSD test, with a single animal as the
experimental unit. For electrophysiological studies, the average
number of evoked spikes for each stimulus was compared between
groups using a two-way nested ANOVAwith group and stimulus as
factors, with neurons nested within rats and rats within groups,
with post hoc Tukey's HSD test. Differences in the ratio of WDR
neurons were compared using a Pearson's chi-square test. The
experimental unit was a single neuron.
Results
FJD induces signiﬁcantly lower mechanical withdrawal thresh-
olds on day 1 than at baseline (P < 0.001), which are also lower than
sham at day 1 (P < 0.001) [Fig. 1(A)]. Thresholds in the sham group
Fig. 1. FJD-induced pain associated with increased NGF expression in the joint. (A) FJD reduced the forepaw withdrawal threshold to mechanical stimulation at day 1 compared to
baseline (#P < 0.001) and sham procedures (*P < 0.001). (B) Representative Western blots show NGF (top) and b-tubulin (bottom) expression in the joint tissue. (C) FJD signiﬁcantly
increased NGF in the joint tissue (*P ¼ 0.031) over levels in sham at day 1. Immunolabeling for NGF increased in the soft tissues surrounding the joint (solid arrows), including the
capsular ligament, at day 1 after FJD (D) compared to labeling in shams (E). Scale bar in (D) is 50 mm and applies to (D) and (E). The ampliﬁed inset boxes in (D) and (E) are 50 mm
wide. CL: capsular ligament; F: inferior facet of the superior vertebra; M: muscle (dashed arrow).
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C7 facet is signiﬁcantly greater after FJD compared to sham
(P ¼ 0.031) [Fig. 1(B) and (C)]. Immunohistochemical labeling of
NGF in C6/C7 facet joints conﬁrms that NGF expression is more
prominent after FJD [Fig. 1(D)] than after sham [Fig. 1(E)].
Consistent with behaviors after injury, the mechanical with-
drawal threshold decreases from baseline 1 day after FJD with
intra-articular injections of vehicle IgG (FJD þ veh) and is main-
tained through day 7 (P < 0.001) [Fig. 2(A)]. The withdrawal
thresholds are unchanged from baseline after sham procedures
(sham þ veh or sham þ anti-NGF) [Fig. 2(A)]. Intra-articular anti-
NGF at injury (FJD þ anti-NGF) inhibits the development of me-
chanical sensitivity, maintaining mechanical withdrawal thresh-
olds at baseline levels comparable to sham þ veh and sham þ anti-
NGF, and greater than FJD þ veh (P < 0.015) withdrawal thresholds
[Fig. 2(A)].
Recordings were made from 186 spinal neurons (depth
620 ± 13 mm for 9 ± 2 applied forepaw stimulus trains and recordedneurons/rat) at day 7 (Table II). Stimulation of the forepaw with
either the 10 g or 26 g ﬁlament evokes signiﬁcantly more spikes for
the FJD þ veh group than for any other group (FJD þ anti-NGF
P < 0.001; sham þ veh P < 0.012; sham þ anti-NGF P < 0.001)
[Fig. 2(B)], with no differences detected between any other groups.
Noxious pinch of the forepaw similarly elicits signiﬁcantly more
evoked spikes in the FJD þ veh group (P < 0.001) [Fig. 2(C)]; there
are no differences in spikes between groups for light brushing of
the paw [Fig. 2(C)]. There is a signiﬁcant effect of injury group on
the proportion of WDR neurons in the spinal cord (P < 0.005), with
the highest frequency of WDR neurons in FJD þ veh [Fig. 2(D)].
Extracellular voltage recordings exhibit increased evoked ﬁring in
the FJD þ veh group [Fig. 2(E)]. The behavioral and electrophysio-
logical studies performed at day 1 after FJD in these same groups
exhibit the same signiﬁcant relationships as at day 7 (data not
shown).
In contrast to anti-NGF injections immediately after injury,
intra-articular anti-NGF injections given 1 day after FJD (FJDþ anti-
Fig. 2. Intra-articular anti-NGF immediately after FJD prevented the development of FJD-induced pain and spinal neuronal hyperexcitability. (A) The forepaw mechanical with-
drawal threshold signiﬁcantly decreased from baseline for FJD þ veh at all times (P < 0.001), with no change from baseline at any time in the FJD þ anti-NGF, sham þ veh, or
sham þ anti-NGF groups. The withdrawal threshold decreased for FJD þ veh compared to FJD þ anti-NGF (*P < 0.015), sham þ veh (#P < 0.001), and sham þ anti-NGF (zP < 0.001) at
all days. (B) At day 7, the number of spikes evoked in spinal neurons by forepaw stimulation with 10 g and 26 g von Frey ﬁlaments signiﬁcantly increased in the FJD þ veh group
compared to all other groups (*#zP < 0.012). There were no differences between FJD þ anti-NGF, sham þ veh, and sham þ anti-NGF for any ﬁlament. (C) The pinch, but not brush,
stimulus evoked signiﬁcantly more spikes in the FJD þ veh group than all others (*#zP < 0.001). (D) There was a signiﬁcant effect of group on the proportion of WDR neurons
(þP < 0.005), with the largest number in the FJD þ veh group. (E) Representative recordings show increased spikes evoked by the 10 g, 26 g, and pinch stimuli in the FJD þ veh
group compared to the other groups.
Table II
Number of neurons recorded for each experimental group
Group Rats/Group Study endpoint (day) Total neurons Neurons/Group Max Neurons/Rat Min Neurons/Rat
FJD þ anti-NGF 6 7 186 65 15 5
FJD þ veh 5 42 11 5
sham þ veh 5 37 10 5
sham þ anti-NGF 5 42 10 6
FJD þ anti-NGFD1 8 7 61 61 11 4
NGF 7 1 91 44 9 3
Vehicle 6 47 10 6
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threshold [Fig. 3(A)]. On day 1 after FJD but before anti-NGF
treatment, the withdrawal threshold decreases from baseline for
the FJD þ anti-NGFD1 group (P < 0.001). The withdrawal threshold
for FJD þ anti-NGFD1 is not different from FJD þ veh at day 1 but is
lower than FJD þ anti-NGF (P < 0.012) [Fig. 3(A)]. After the intra-
articular injection of the anti-NGF antibody given on day 1, the
withdrawal threshold remains signiﬁcantly lower than baseline
(P < 0.028) as well as FJD þ anti-NGF (P < 0.043) at all timepoints
and is not different from FJD þ veh on any day [Fig. 3(A)].
Quantiﬁcation of evoked spikes from 61 spinal neurons (depth
724 ± 25 mm for 8 ± 3 applied forepaw stimulus trains and recorded
neurons/rat) at day 7 after FJD þ anti-NGFD1 (Table II) indicates
more ﬁring evoked by the 26 g ﬁlament compared to FJD þ anti-
NGF (P < 0.022); spike counts for that ﬁlament are not different
between the FJD þ anti-NGFD1 and FJD þ veh groups [Fig. 3(B)].
However, the number of spikes evoked by the noxious pinch for the
FJD þ anti-NGFD1 group is signiﬁcantly lower than FJD þ veh
(P < 0.001) and is not different from FJD þ anti-NGF. Extracellular
voltage recordings show the differences between groups for the
26 g and pinch stimuli [Fig. 3(C)e(E)].
Intra-articular NGF is sufﬁcient to induce behavioral and spinal
neuronal hypersensitivity [Fig. 4]. The withdrawal threshold
signiﬁcantly decreases at day 1 (P < 0.010) but returns to baseline
for all later times [Fig. 4(A)]. Intra-articular PBS does not alter the
withdrawal threshold [Fig. 4(A)]. For rats followed for only 1 day
after intra-articular NGF injections, the withdrawal threshold is
decreased at day 1 compared to baseline and to the vehicle group
(P < 0.001) [Fig. 4(B)]. Because NGF induces behavioral sensitivity
that is evident only on day 1 (Fig. 4), spinal neuronal excitability
was only assessed at 1 day after injection. 91 mechanosensitiveFig. 3. Inhibiting intra-articular NGF signaling at day 1 after FJD did not alter pain or spinal
after FJD þ veh compared to FJD þ anti-NGF (*P < 0.041). FJD þ anti-NGFD1 also exhibited d
there were fewer spikes evoked by noxious von Frey stimulation (26 g) for FJD þ anti-NGF re
NGF (*P < 0.001) and FJD þ anti-NGFD1 (þP < 0.001) exhibited fewer evoked spikes than F
pinch stimuli for each group. Datasets for the FJD þ veh and FJD þ anti-NGF groups are respinal neurons with input from the forepaw were recorded (depth
681 ± 22 mm; for 8 ± 2 forepaw stimulus trains and recorded
neurons/rat) (Table II). Stimulation with all von Freys evoke
increased ﬁring in the NGF group compared to vehicle [Fig. 4(C)]. A
trend towards increased ﬁring at each ﬁlament strength is evident
in the NGF group but is only signiﬁcant for the noxious 26 g ﬁla-
ment (P < 0.04) [Fig. 4(D)]. Signiﬁcantly more neurons are classiﬁed
as WDR on day 1 after NGF (93.2%) than after vehicle (74.5%)
(P ¼ 0.016) [Fig. 4(E)].
Discussion
This study establishes a role for intra-articular NGF in the
development of facet joint-mediated pain. NGF increases in the
injured joint early after its painful injury, and local administration
of anti-NGF immediately after injury prevents the development of
both behavioral and spinal neuronal hypersensitivity. However,
delayed administration of intra-articular anti-NGF, even at 1 day
after injury, does not alter the behavioral or associated von Frey-
evoked spinal neuronal sensitivity. Because NGF increases in the
joint after injury in parallel with onset of pain and spinal neuronal
hyperexcitability, we determined if intra-articular NGF alone is
sufﬁcient to induce those changes. Exogenous intra-articular NGF
induces pain that lasts for only 1 day, further implicating intra-
articular NGF in the initiation of joint pain.
Intra-articular NGF increases in the facet after a painful injury,
similar to ﬁndings in experimental arthritis11,25. In inﬂamed tissues,
there is increased NGF release from immune cells14, and elevated
NGF has been reported in the soft tissues of experimental knee
arthritis11. These modiﬁcations have also been reported in the sy-
novial ﬂuid of painful inﬂamed and arthritic joints inneuronal hyperexcitability. (A) The forepaw withdrawal threshold decreased at all days
ecreased thresholds at all days compared to FJD þ anti-NGF (#P < 0.043). (B) At day 7,
lative to FJD þ veh (*P < 0.002) and FJD þ anti-NGFD1 (#P < 0.022), but both FJD þ anti-
JD þ veh for a noxious pinch. (CeE) Representative spikes are shown for the 26 g and
produced from Fig. 2.
Fig. 4. Intra-articular NGF induced transient behavioral sensitivity that was associated with spinal neuronal hyperexcitability. (A) Intra-articular NGF signiﬁcantly reduced the
withdrawal threshold from baseline at day 1 (*P < 0.010), but it returned to baseline by day 3. Injection of PBS vehicle did not alter the withdrawal threshold from baseline at any
day. (B) At 1 day after intra-articular NGF the withdrawal threshold signiﬁcantly decreased relative to baseline (*P < 0.001) and to vehicle injection (zP < 0.001). (C) Representative
extracellular recordings in the spinal cord at day 1 demonstrated increased evoked neuronal ﬁring after NGF. (D) The number of evoked spikes signiﬁcantly increased (zP < 0.040)
for the noxious 26 g ﬁlament after NGF injection. (E) Intra-articular NGF increased the number of spinal neurons classiﬁed as WDR neurons compared to the number identiﬁed after
intra-articular vehicle administration (zP ¼ 0.016).
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also potential sources of NGF35. Although the cellular source(s) of
NGF in the facet joint must be deﬁned, upregulation of the in-
ﬂammatory mediator PGE2 has been reported in this model24 when
intra-articular NGF is increased, suggesting that increasemay result
from joint inﬂammation. Because intra-articular NGF induces pain,
albeit transiently, elevated intra-articular NGF may be a source of
clinical joint pain, especially since intradermal and intramuscular
NGF induce pain in humans15,36. The intra-articular injection itself
may stimulate joint afferents by capsule distension37. Yet, neitherjoint afferent activation nor stimulation of surrounding tissues is
likely to contribute to the current ﬁndings since no changes in any
outcomes were evident in volume-matched vehicle control injec-
ted rats. The elevated intra-articular NGF that is evident across
several types of painful conditions, together with the fact that local
anti-NGF prevents pain, suggests that regardless of the etiology,
NGF is involved in a broad range of painful joint conditions,
including other joint injuries and arthritis.
Preventing pain by immediate, but not delayed (day 1), intra-
articular anti-NGF supports traumatic joint pain being mediated
J.V. Kras et al. / Osteoarthritis and Cartilage 23 (2015) 1999e20082006by early NGF signaling cascades. Yet, NGF-induced pain is only
transient, so NGF is not the sole mediator. Because painful FJD is
also associated with increases in PGE2 at day 124, which itself reg-
ulates inﬂammation and pain38, NGF may facilitate pain by
increasing the duration of PGE2-mediated behavioral hypersensi-
tivity39,40. Such priming may explain why intra-articular NGF in-
duces only short-lasting pain and intra-articular anti-NGF given at,
but not after, injury prevents long-lasting facet pain. Early block of
NGFmay prevent nociceptor priming after injury. An intra-articular
NSAID, which disrupts prostaglandin synthesis, reverses estab-
lished facet joint pain, but only when given one day after injury10.
The different effects of the anti-NGF and NSAID may be due to early
NGF facilitating later PGE2-mediated nociception; although NGF is
sufﬁcient to initiate pain, additional mediatorsmay contribute to its
maintenance.
It is unknown if painful FJD also induces joint degeneration.
Joint laxity contributes to post-traumatic osteoarthritis41, so altered
facet kinematics from joint laxity after injury may promote later
degeneration. Indeed, joint laxity increases after this painful facet
injury42. Further, joint inﬂammation is evident in both post-
traumatic and chemically-induced osteoarthritis43e45. It is, there-
fore, possible that our ﬁndings, along with evidence of early in-
ﬂammatory responses following FJD10,24, may reﬂect initial stages
of a degenerative process. Transient pain is evident in a rat model of
facet osteoarthritis in association with inﬂammation, but that pain
also returns weeks later when joint degeneration is severe44. Since
our latest endpoint is day 7, it is likely that joint degeneration does
not contribute to the responses observed here. Increased intra-
articular NGF is reported as late as four weeks after knee osteoar-
thritis induction in the rat11, suggesting intra-articular NGF may
contribute to pain maintenance during joint degeneration. We did
not probe later time points, and NGF expression was only quanti-
ﬁed at day 1. Because behavioral hypersensitivity lasts for at least
six weeks in this model46, studies are needed to deﬁne relation-
ships between mechanical facet joint injury, intra-articular NGF,
joint degeneration, and persistent pain.
Intra-articular NGF also induces dorsal horn neuron hyperex-
citability. Not surprisingly, that hyperexcitability is only evident for
a 26 g stimulation, which is expected given the paw withdrawal
threshold of slightly greater than 10 g. Many of the neurons in the
deep dorsal horn are WDR neurons, responding to both non-
noxious and noxious signals38,47. WDRs contribute to central
sensitization and many forms of persistent pain5,38. Intra-articular
NGF increases the number of neurons responding to mechanical
stimulation as WDRs. Increases in spinal neuronal excitability and
WDRs suggest that intra-articular NGF may mediate central mod-
iﬁcations underlying joint pain. One common consequence of
central sensitization is expansion of sensory neuron receptive
ﬁelds38, which has been reported for monoarthritis in the rat knee5.
Whiplash patients exhibit hypersensitivity to mechanical stimuli in
the neck, as well as in the shoulder, arm, and hand48,49. Intra-
articular NGF in the facet inducing behavioral hypersensitivity in
the forepaw further supports central sensitization in traumatic
facet-mediated pain.
Painful facet joint injury increases dorsal horn neuronal excit-
ability and shifts neurons from LTMs to WDRs7,9. Because NGF in-
creases in the facet after its injury and is sufﬁcient to induce pain
and spinal neuronal hyperexcitability, early activity of intra-
articular NGF likely mediates injury-induced facet pain. Adminis-
tration of intra-articular anti-NGF immediately after joint injury
prevents behavioral hypersensitivity and spinal neuronal hyper-
excitability. Although current systemic anti-NGF therapies alleviate
osteoarthritic joint pain and chronic low back pain, they are asso-
ciated with many adverse events, including joint degeneration19,50.
Our ﬁndings suggest local anti-NGF treatment to be effective forpreventing traumatic joint pain. All rats receiving local anti-NGF in
our study exhibited normal weight gain and grooming behavior
and were indistinguishable from controls, with no obvious ill-
effects.
In contrast to the effects of immediate intra-articular anti-NGF
application, delayed intra-articular anti-NGF even 1 day after injury
does not mitigate the pain or spinal neuronal ﬁring evoked by
ﬁlament stimuli. Despite not affecting neuronal ﬁring evoked by
von Frey stimulation, intra-articular anti-NGF on day 1 reduces
pinch-evoked ﬁring. The mechanism by which this occurs is
currently unknown, but this differential effect warrants further
study to identify that mechanism. Interestingly, a fast-acting
anesthetic prevents the development of both of these correlates
onlywhen givenwithin 8 h of injury29. As such, studies varying the
timing of anti-NGF treatment are needed to fully evaluate whether
this more-speciﬁc, local treatment is effective in alleviating facet
joint pain and is associated with fewer adverse events than sys-
temic anti-NGF treatment for joint pain. Nevertheless, the pre-
vention of injury-induced pain and neuronal hyperexcitability
achieved by anti-NGF demonstrates that intra-articular NGF is
necessary for the development of joint pain after facet injury.
Summarizing, these data demonstrate a role for intra-articular
NGF in the development of pain and spinal neuronal hyperexcit-
ability following facet injury. Despite reports of increased NGF in
degenerative and arthritic joints11,20,25,26, this is the ﬁrst study to
establish that intra-articular NGF induces pain and spinal neuronal
sensitization. Intra-articular anti-NGF given immediately after joint
injury prevents pain development; yet, with a 1 day delay, that
same dose is ineffective. Because only a single dose of anti-NGFwas
used, different anti-NGF treatment regimensmay identify potential
treatments for established pain and the intra-cellular signaling
mechanisms through which NGF contributes to hyperexcitability of
spinal neurons and the maintenance of joint pain. Regardless, this
study provides the ﬁrst evidence that intra-articular NGF is both
necessary and sufﬁcient for the development of joint-mediated
pain and spinal neuronal hyperexcitability, identifying it as an
intra-articular initiator of joint injury-induced pain and supporting
early localized treatment targeting NGF as potential effective
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